Amedeo Smart

Free Medical Literature Service

 

Amedeo

Thoracic Surgery
  Free Subscription

Articles published in
Eur Heart J
    April 2024
  1. PIBAROT P
    Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes.
    Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093.
    >> Share

  2. KIM YY, Lluri G, Haeffele C, Daugherty T, et al
    Hepatocellular carcinoma in survivors after Fontan operation: a case-control study.
    Eur Heart J. 2024;45:1477-1480.
    >> Share

  3. VERGALLO R, Galiuto L
    Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
    Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
    >> Share

  4. BLEIZIFFER S
    Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go.
    Eur Heart J. 2024;45:1125-1126.
    >> Share

  5. WINDECKER S, Gilard M, Achenbach S, Cribier A, et al
    Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.
    Eur Heart J. 2024;45:1104-1115.
    >> Share

  6. WAYDA B
    Machine perfusion of marginal donor hearts: a valuable tool, but where and for whom?
    Eur Heart J. 2024;45:1178.
    >> Share

  7. AMESZ JH, Taverne YJHJ, Manintveld OC
    To transplant or not to transplant 'marginal' donor hearts: is machine perfusion the answer?
    Eur Heart J. 2024;45:1177.
    >> Share

    March 2024
  8. BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al
    Great debate: symptomatic moderate aortic stenosis should undergo intervention.
    Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093.
    >> Share

  9. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    >> Share

  10. MEHILLI J
    Shortening in-hospital stay after transcatheter aortic valve implantation: a deja vu in percutaneous interventions.
    Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093.
    >> Share

  11. DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al
    Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
    Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093.
    >> Share

  12. MAISANO F, Hahn R, Sorajja P, Praz F, et al
    Transcatheter treatment of the tricuspid valve: current status and perspectives.
    Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093.
    >> Share

    February 2024
  13. WU J, Zafar MA, Elefteriades JA
    Decision-making in aortic disease.
    Eur Heart J. 2024;45:633-634.
    >> Share

  14. LURZ P, Kresoja KP
    Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
    Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
    >> Share

  15. LUDWIG S, Granada JF
    Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward.
    Eur Heart J. 2024 Feb 8:ehae013. doi: 10.1093.
    >> Share

  16. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    >> Share

    January 2024
  17. SENIOR R, Khattar RS
    To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
    Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
    >> Share

  18. NAKAJIMA A, Okutsu M, Nakamura S
    Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy.
    Eur Heart J. 2024;45:315.
    >> Share

  19. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    >> Share

  20. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    >> Share

  21. HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al
    Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
    Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093.
    >> Share

  22. CAPRANZANO P, Moliterno D, Capodanno D
    Aspirin-free antiplatelet strategies after percutaneous coronary interventions.
    Eur Heart J. 2024 Jan 18:ehad876. doi: 10.1093.
    >> Share

  23. NAKAMURA K, Taniguchi T, Furukawa Y
    Haemolytic anaemia after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 18:ehae010. doi: 10.1093.
    >> Share

  24. VERGALLO R, Galiuto L
    Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery.
    Eur Heart J. 2024 Jan 18:ehae006. doi: 10.1093.
    >> Share

  25. HAMILTON DE, Albright J, Seth M, Painter I, et al
    Merging machine learning and patient preference: a novel tool for risk prediction of percutaneous coronary interventions.
    Eur Heart J. 2024 Jan 17:ehad836. doi: 10.1093.
    >> Share

  26. ABOULHOSN J
    Sapien S3 transcatheter pulmonary valve replacement: an excellent option but not a panacea.
    Eur Heart J. 2024;45:211-213.
    >> Share

  27. HASCOET S, Bentham JR, Giugno L, Betrian-Blasco P, et al
    Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.
    Eur Heart J. 2024;45:198-210.
    >> Share

  28. SIONTIS GCM, Coles B, Haner JD, McGovern L, et al
    Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium.
    Eur Heart J. 2024;45:161-177.
    >> Share

  29. KADDOURA R, Al-Hijji M
    The evolution of transcatheter valvular interventions: current evidence.
    Eur Heart J. 2024;45:10-14.
    >> Share

    December 2023
  30. HUANG F, Ammirati E, Ponnaiah M, Montero S, et al
    Fulminant myocarditis proven by early biopsy and outcomes.
    Eur Heart J. 2023;44:5110-5124.
    >> Share

  31. LI XM, Zhu XJ, Jing ZC
    Reverse cardiac remodelling after balloon atrial septostomy for pulmonary arterial hypertension and end-stage heart failure.
    Eur Heart J. 2023 Dec 16:ehad822. doi: 10.1093.
    >> Share

  32. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    >> Share

  33. BIENSTOCK SW, Stone GW
    From TriValve to TRILUMINATE to TRISCEND: what have we learned?
    Eur Heart J. 2023;44:4874-4877.
    >> Share

  34. ALFONSO F, Marschall A, Rivero F
    Revascularization for left main coronary artery disease.
    Eur Heart J. 2023;44:4893.
    >> Share

  35. PERSSON J, Ivert T, Omerovic E
    Observational studies are needed to complete the body of evidence for left main coronary artery disease revascularization strategies.
    Eur Heart J. 2023;44:4894.
    >> Share

  36. FLORES-UMANZOR E, Cepas-Guillen P, Freixa X
    Enhancing success rate in transcatheter closure of paravalvular leaks post-TAVI with vascular plug technology.
    Eur Heart J. 2023;44:4810.
    >> Share

    November 2023
  37. VERGALLO R, Volpe M
    Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients.
    Eur Heart J. 2023 Nov 29:ehad803. doi: 10.1093.
    >> Share

  38. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    >> Share

  39. VERGALLO R, Volpe M
    Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?
    Eur Heart J. 2023 Nov 28:ehad792. doi: 10.1093.
    >> Share

  40. WAYDA B, Angleitner P, Smits JM, van Kins A, et al
    Disparities in donor heart acceptance between the USA and Europe: clinical implications.
    Eur Heart J. 2023;44:4665-4674.
    >> Share

  41. ZHAO Y, Chen Y
    What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in high-bleeding risk: 1 month or 3 months?
    Eur Heart J. 2023 Nov 20:ehad728. doi: 10.1093.
    >> Share

  42. PEDICINO D, Liuzzo G
    Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?
    Eur Heart J. 2023 Nov 18:ehad733. doi: 10.1093.
    >> Share

  43. TOMII D, Praz F, Windecker S
    Guideline directed medical therapy in patients with heart failure undergoing transcatheter edge-to-edge mitral valve repair: unfulfilled premise.
    Eur Heart J. 2023 Nov 15:ehad678. doi: 10.1093.
    >> Share

  44. PATEL KP, Baumbach A
    Timing treatment for tricuspid regurgitation.
    Eur Heart J. 2023 Nov 9:ehad768. doi: 10.1093.
    >> Share

  45. ACKLAND GL, Patel A, Abbott TEF, Begum S, et al
    Discontinuation vs. continuation of renin-angiotensin system inhibition before non-cardiac surgery: the SPACE trial.
    Eur Heart J. 2023 Nov 7:ehad716. doi: 10.1093.
    >> Share

  46. BOULET J, Mehra MR
    Crossing the chasm of donor organ recovery in heart transplantation.
    Eur Heart J. 2023 Nov 4:ehac707. doi: 10.1093.
    >> Share

  47. KIM H, Kang DY, Lee J, Choi Y, et al
    Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
    Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
    >> Share

  48. BYRNE RA, Fremes S, Capodanno D, Czerny M, et al
    2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
    Eur Heart J. 2023;44:4310-4320.
    >> Share

  49. CREA F
    Hot topics in interventional cardiology: left main disease, heavily calcified coronary stenoses, and physiology-guided percutaneous coronary interventions.
    Eur Heart J. 2023;44:4295-4299.
    >> Share

  50. KODALI S, Hahn RT, Makkar R, Makar M, et al
    Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.
    Eur Heart J. 2023 Nov 1:ehad667. doi: 10.1093.
    >> Share

    October 2023
  51. HARARI E, Landes U
    Post-Transcatheter Aortic Valve Implantation paravalvular leak: multiple aetiologies and no panacea.
    Eur Heart J. 2023 Oct 28:ehad696. doi: 10.1093.
    >> Share

  52. KALINCZUK L, Skotarczak W, Sondergaard L, Mintz GS, et al
    Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement.
    Eur Heart J. 2023 Oct 20:ehad683. doi: 10.1093.
    >> Share

  53. ARORA S, Zimmermann FM, Solberg OG, Nytroen K, et al
    Prognostic value of intravascular ultrasound early after heart transplantation.
    Eur Heart J. 2023 Oct 18:ehad648. doi: 10.1093.
    >> Share

  54. WIJESURENDRA RS, Sardell R, Jayaram R, Samuel N, et al
    Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial.
    Eur Heart J. 2023 Oct 4:ehad640. doi: 10.1093.
    >> Share

  55. FARJAT-PASOS JI, Dumont E, Paradis JM
    Optimizing transcatheter mitral valve replacement with direct, continuous transvalvular haemodynamic evaluation: first-in-man.
    Eur Heart J. 2023 Oct 4:ehad603. doi: 10.1093.
    >> Share

  56. HAHN RT, Lawlor MK, Davidson CJ, Badhwar V, et al
    Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
    Eur Heart J. 2023 Oct 4:ehad653. doi: 10.1093.
    >> Share

    September 2023
  57. VERGALLO R, Volpe M
    Light the FIRE of revascularization in older patients with myocardial infarction.
    Eur Heart J. 2023 Sep 28:ehad638. doi: 10.1093.
    >> Share

  58. BEYGUI F, Guillemot V, Saloux E
    Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
    Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093.
    >> Share

  59. KI YJ, Han K, Kim HS, Han JK, et al
    Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study.
    Eur Heart J. 2023 Sep 26:ehad616. doi: 10.1093.
    >> Share

  60. BORLAUG BA, Schaff HV, Asirvatham SJ, Koepp KE, et al
    Surgical pericardiotomy to treat heart failure with preserved ejection fraction: a first clinical study.
    Eur Heart J. 2023 Sep 22:ehad620. doi: 10.1093.
    >> Share

  61. MOORE JP, Aboulhosn JA, Khairy P
    Electrophysiology testing before transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot.
    Eur Heart J. 2023;44:3228-3230.
    >> Share


  62. Correction to: 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the Europ
    Eur Heart J. 2023 Sep 7:ehad577. doi: 10.1093.
    >> Share

  63. FENG S, Wu F, Pan X
    Computational fluid dynamics as a novel method to predict haemodynamic changes and guide transcatheter edge-to-edge repair.
    Eur Heart J. 2023;44:3199.
    >> Share

  64. CREA F
    TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
    Eur Heart J. 2023;44:3105-3109.
    >> Share

    August 2023
  65. BERRY C, McClure JD, Oldroyd KG
    Coronary revascularization guided by instantaneous wave-free ratio compared to fractional flow reserve: pooled 5-year mortality in the DEFINE-FLAIR and iFR-SWEDEHEART trials.
    Eur Heart J. 2023 Aug 27:ehad552. doi: 10.1093.
    >> Share

  66. EFTEKHARI A, Holck EN, Westra J, Olsen NT, et al
    Five-year major cardiovascular events are increased when coronary revascularization is guided by instantaneous wave-free ratio compared to fractional flow reserve: a pooled analysis of iFR-SWEDEHEART and DEFINE-FLAIR trials.
    Eur Heart J. 2023 Aug 27:ehad582. doi: 10.1093.
    >> Share

  67. VARSHNEY AS, Shah M, Vemulapalli S, Kosinski A, et al
    Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry.
    Eur Heart J. 2023 Aug 26:ehad584. doi: 10.1093.
    >> Share

  68. DREYFUS J, Galloo X, Taramasso M, Heitzinger G, et al
    TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.
    Eur Heart J. 2023 Aug 25:ehad585. doi: 10.1093.
    >> Share

  69. PRENDERGAST BD, Patterson T, Redwood S
    Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
    Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
    >> Share

  70. MCENTEGART M, Gori T
    How to treat left main coronary artery disease: the complementary lessons from trials and registries.
    Eur Heart J. 2023;44:2843-2845.
    >> Share

  71. PERSSON J, Yan J, Angeras O, Venetsanos D, et al
    PCI or CABG for left main coronary artery disease: the SWEDEHEART registry.
    Eur Heart J. 2023;44:2833-2842.
    >> Share

  72. AL ZAIDI M, Nickenig G, Zimmer S
    Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
    Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
    >> Share

  73. VAN KLEI WA, van Waes JAR, Beattie WS
    Routine post-operative troponin surveillance after non-cardiac surgery: are we ready?
    Eur Heart J. 2023 Aug 1:ehad487. doi: 10.1093.
    >> Share

    July 2023
  74. IUNG B, Pierard L, Magne J, Messika-Zeitoun D, et al
    Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement.
    Eur Heart J. 2023 Jul 28:ehad355. doi: 10.1093.
    >> Share

  75. FAZEL R, Yeh RW, Cohen DJ, Rao SV, et al
    Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA.
    Eur Heart J. 2023 Jul 19:ehad430. doi: 10.1093.
    >> Share

  76. HAMILTON GW, Raman J, Moten S, Matalanis G, et al
    Radial artery vs. internal thoracic artery or saphenous vein grafts: 15-year results of the RAPCO trials.
    Eur Heart J. 2023;44:2406-2408.
    >> Share

  77. GOLTSTEIN LCMJ, Rooijakkers MJP, Hoeks M, Li WWL, et al
    Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis.
    Eur Heart J. 2023 Jul 5:ehad340. doi: 10.1093.
    >> Share

  78. BADIMON L, Mendieta G, Vilahur G
    Statins revisited: therapeutic applications beyond lipid lowering?
    Eur Heart J. 2023;44:2332-2334.
    >> Share

  79. LORENZATTI D, Pina P, Slipczuk L
    Cardiovascular computed tomography in the evaluation of post-TAVI prosthesis dysfunction: the thin line between hypo attenuated leaflet thickening and clinical valve thrombosis.
    Eur Heart J. 2023;44:2350.
    >> Share

    June 2023
  80. NOTENBOOM ML, Schuermans A, Etnel JRG, Veen KM, et al
    Paediatric aortic valve replacement: a meta-analysis and microsimulation study.
    Eur Heart J. 2023 Jun 27:ehad370. doi: 10.1093.
    >> Share

  81. GOEL K, Shah P, Jones BM, Korngold E, et al
    Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
    Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
    >> Share

  82. AMIN H, Noor HA, Bardooli F, Yousif N, et al
    Implementation of a national primary percutaneous coronary intervention program for ST-segment elevation myocardial infarction in the Kingdom of Bahrain: an inspiring success story from a centre of excellence.
    Eur Heart J. 2023 Jun 17:ehad329. doi: 10.1093.
    >> Share

  83. PEDICINO D, Vergallo R
    Long-lasting effects of transcatheter repair of secondary mitral regurgitation: the latest lesson from COAPT trial.
    Eur Heart J. 2023 Jun 14:ehad349. doi: 10.1093.
    >> Share

  84. SMALL AM, Libby P
    Why Y? The Y chromosome may serve a cardiovascular purpose after all.
    Eur Heart J. 2023;44:1953-1955.
    >> Share

    May 2023
  85. HALVORSEN S, Mehilli J, Geisler T
    Continue or discontinue aspirin before non-cardiac surgery?
    Eur Heart J. 2023 May 8:ehad246. doi: 10.1093.
    >> Share

  86. HAN Y, Sun Z, Fan T
    Simultaneous percutaneous closure of aortic paravalvular leak and residual shunt of ventricular septal defect.
    Eur Heart J. 2023;44:1577.
    >> Share

    April 2023
  87. VERGALLO R, Liuzzo G
    Intravascular imaging to guide percutaneous coronary intervention of complex lesions: time to renovate guidelines?
    Eur Heart J. 2023 Apr 26:ehad243. doi: 10.1093.
    >> Share

  88. HALVORSEN S, Mehilli J, Mueller C
    The roles of cardiac troponins before non-cardiac surgery.
    Eur Heart J. 2023 Apr 26:ehad226. doi: 10.1093.
    >> Share

  89. BEN-BARUCH GOLAN Y, Zahger D
    Routine troponin testing before non-cardiac surgery: does the evidence justify the consequences?
    Eur Heart J. 2023 Apr 26:ehad227. doi: 10.1093.
    >> Share

  90. LEE J, Kim JS, Shim CY
    MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
    >> Share

  91. LIAKOPOULOS OJ, Kuhn EW, Hellmich M, Schlomicher M, et al
    Statin loading before coronary artery bypass grafting: a randomized trial.
    Eur Heart J. 2023 Apr 22:ehad238. doi: 10.1093.
    >> Share

  92. PEDICINO D, Vergallo R
    Transcatheter repair for severe tricuspid regurgitation: are we going in the right direction?
    Eur Heart J. 2023 Apr 22:ehad219. doi: 10.1093.
    >> Share

  93. TOMOAIA R, Sandu I, Beyer RS
    Fatal infective endocarditis early after TAVR.
    Eur Heart J. 2023;44:1478.
    >> Share

  94. GENTILE D, Iannaccone M, Chieffo A
    Drug-coated balloons: from treatment of in-stent restenosis to extended indications. What's next?
    Eur Heart J. 2023;44:1357-1359.
    >> Share

  95. COLOMBO A, Leone PP
    Redefining the way to perform percutaneous coronary intervention: a view in search of evidence.
    Eur Heart J. 2023 Apr 11:ehad215. doi: 10.1093.
    >> Share

  96. MITSUI K, Fujino M, Noguchi T
    Left internal thoracic artery bypass graft.
    Eur Heart J. 2023;44:1284.
    >> Share

    March 2023
  97. KAGASE A, Yamamoto M, Tokuda T
    Successful bailout clipping for rare complication of anterior mitral leaflet dissection during transcatheter edge-to-edge mitral valve repair.
    Eur Heart J. 2023 Mar 29:ehad163. doi: 10.1093.
    >> Share

  98. XIE Z, Zhu H
    A rare case of mitral regurgitation caused by primary aldosteronism.
    Eur Heart J. 2023 Mar 29:ehad180. doi: 10.1093.
    >> Share

  99. CHEN YH, Chang HH, Leu HB
    Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration.
    Eur Heart J. 2023 Mar 25:ehad164. doi: 10.1093.
    >> Share

  100. CIARDETTI N, Nardi G, Di Mario C
    Direct high-frequency intravascular ultrasound visualization of drug delivery after paclitaxel urea eluting balloon angioplasty.
    Eur Heart J. 2023;44:1096.
    >> Share

  101. HONDA Y, Nishihira K, Shibata Y, Asada Y, et al
    Early-phase restenosis following directional coronary atherectomy and paclitaxel-coated balloon angioplasty: a histopathological analysis.
    Eur Heart J. 2023;44:1098.
    >> Share

  102. MAS-PEIRO S, Abplanalp WT, Rasper T, Berkowitsch A, et al
    Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement.
    Eur Heart J. 2023 Mar 18:ehad093. doi: 10.1093.
    >> Share

  103. CHUNG CJ, Otto CM
    Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation.
    Eur Heart J. 2023 Mar 9:ehad151. doi: 10.1093.
    >> Share

  104. LANDES U, Hochstadt A, Manevich L, Webb JG, et al
    Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications.
    Eur Heart J. 2023 Mar 8:ehad146. doi: 10.1093.
    >> Share

  105. RODES-CABAU J, Nuche J
    Are contemporary TAVI results influenced by hospital volume?
    Eur Heart J. 2023;44:868-870.
    >> Share

  106. CHEN J, Yang Y, Wei L
    One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation.
    Eur Heart J. 2023 Mar 3:ehad094. doi: 10.1093.
    >> Share

    February 2023

  107. Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respi
    Eur Heart J. 2023 Feb 23:ehad005. doi: 10.1093.
    >> Share

  108. CHEN CB, Jarrett H, Goldman SM
    Candida endocarditis in a transcatheter aortic valve.
    Eur Heart J. 2023 Feb 13:ehad070. doi: 10.1093.
    >> Share

    January 2023

  109. Corrigendum to: Dual versus single antiplatelet therapy after transcatheter aortic valve replacement: a systematic review and meta-analysis.
    Eur Heart J. 2023 Jan 31:ehad047. doi: 10.1093.
    >> Share

  110. GAUDINO M, Di Franco A, Rong LQ, Piccini J, et al
    Postoperative atrial fibrillation: from mechanisms to treatment.
    Eur Heart J. 2023 Jan 31:ehad019. doi: 10.1093.
    >> Share

  111. PUELACHER C, Gualandro DM, Glarner N, Lurati Buse G, et al
    Long-term outcomes of perioperative myocardial infarction/injury after non-cardiac surgery.
    Eur Heart J. 2023 Jan 27:ehac798. doi: 10.1093.
    >> Share

  112. ZHANG T, Yang X, Song J, Shi Y, et al
    Emergent transcatheter aortic valve implantation combined with enterectomy for acute decompensated heart failure caused by severe aortic stenosis and strangulated femoral hernia.
    Eur Heart J. 2023 Jan 26:ehad007. doi: 10.1093.
    >> Share

  113. BUTCHER SC, Essayagh B, Steyerberg EW, Benfari G, et al
    Factors influencing post-surgical survival in degenerative mitral regurgitation.
    Eur Heart J. 2023 Jan 26:ehad004. doi: 10.1093.
    >> Share

  114. AHMAD Y, Howard JP, Arnold AD, Madhavan MV, et al
    Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials.
    Eur Heart J. 2023 Jan 20:ehac642. doi: 10.1093.
    >> Share

  115. PILGRIM T, Siontis GCM, Windecker S
    Transcatheter aortic valve implantation: a blueprint for evidence-based evaluation of technological innovation.
    Eur Heart J. 2023 Jan 20:ehac635. doi: 10.1093.
    >> Share

  116. KANAMURA T, Hashimoto T, Shiose A, Tsutsui H, et al
    Thrombus associated with locked-in atrial fibrillation in recipient remnant left atrium after heart transplantation.
    Eur Heart J. 2023 Jan 20:ehad008. doi: 10.1093.
    >> Share

  117. LEE G, Chikwe J, Milojevic M, Wijeysundera HC, et al
    ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis.
    Eur Heart J. 2023 Jan 12:ehac803. doi: 10.1093.
    >> Share

  118. CHIETERA F, Saia F, Palmerini T
    Post-traumatic acute aortic regurgitation due to cusp rupture in non-calcific bicuspid valve treated with ballon-expandable transcatheter heart valve.
    Eur Heart J. 2023 Jan 12:ehac805. doi: 10.1093.
    >> Share

  119. OMRAN H
    Troponin for risk stratification after CABG: just one piece of the puzzle.
    Eur Heart J. 2023;44:163-164.
    >> Share

  120. CHEN T, Zhou H, Guo J, Chen Y, et al
    Intravascular ultrasound and ultrasonic flow ratio-guided zero-contrast rotational atherectomy for calcified coronary lesions.
    Eur Heart J. 2023;44:166.
    >> Share

    December 2022

  121. Erratum to: The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.
    Eur Heart J. 2022 Dec 28:ehac815. doi: 10.1093.
    >> Share

  122. SALAUN E, Villeneuve J, Voisine P
    Unexpected find of native aortic leaflet thrombus during surgical myocardial revascularization.
    Eur Heart J. 2022;43:5064.
    >> Share

  123. ARFAEE M, Vis A, Kluin J
    Future technologies in total artificial heart development: can a robot become as good as a donor heart?
    Eur Heart J. 2022;43:4970-4972.
    >> Share

  124. MEHILLI J, Halvorsen S
    The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.
    Eur Heart J. 2022 Dec 17:ehac703. doi: 10.1093.
    >> Share

  125. HOUEIJEH A, Domanski O, Bouzguenda I
    Multimodality fusion imaging to plan and to guide complex coronary fistula closure.
    Eur Heart J. 2022;43:4851.
    >> Share

  126. MONSUEZ JJ, Gatzov P, Ferreira-Gonzalez I, Alfonso F, et al
    Coronary interventions 2021: insights from the National Societies of Cardiology Journals of the European Society of Cardiology.
    Eur Heart J. 2022 Dec 7:ehac679. doi: 10.1093.
    >> Share

  127. COSTA F, Montalto C, Branca M, Hong SJ, et al
    Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
    Eur Heart J. 2022 Dec 7:ehac706. doi: 10.1093.
    >> Share

  128. ANDREOTTI F, Geisler T, Collet JP, Gigante B, et al
    Acute, periprocedural and longterm antithrombotic therapy in older adults.
    Eur Heart J. 2022 Dec 7:ehac515. doi: 10.1093.
    >> Share

  129. JAMAL J, Idris H, Faour A, Yang W, et al
    Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention.
    Eur Heart J. 2022 Dec 2:ehac661. doi: 10.1093.
    >> Share

  130. HAN Y
    Chinese guidelines for percutaneous coronary intervention in patients with left main bifurcation disease.
    Eur Heart J. 2022 Dec 2:ehac625. doi: 10.1093.
    >> Share

    November 2022
  131. SCOTTI A, Coisne A, Taramasso M, Granada JF, et al
    Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation.
    Eur Heart J. 2022 Nov 29:ehac735. doi: 10.1093.
    >> Share

  132. WANG B, Lee RJ, Tao L
    First-in-human transcatheter endocardial alginate-hydrogel implantation for the treatment of heart failure.
    Eur Heart J. 2022 Nov 24:ehac671. doi: 10.1093.
    >> Share

  133. CREA F
    Controversies in cardiac surgery: left main coronary disease, arterial myocardial revascularization, and prosthetic valves in dialysis.
    Eur Heart J. 2022;43:4603-4605.
    >> Share

  134. KIM KS, Belley-Cote E, Whitlock RP
    What is the optimal prosthetic valve in dialysis?
    Eur Heart J. 2022;43:4657-4659.
    >> Share

  135. MOTOVSKA Z, Akin I
    The art of selection in coronary bypass grafting.
    Eur Heart J. 2022;43:4653-4656.
    >> Share

  136. TAGGART DP, Audisio K, Gerry S, Robinson NB, et al
    Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial.
    Eur Heart J. 2022;43:4644-4652.
    >> Share

  137. PATHAK S, Lai FY, Miksza J, Petrie MC, et al
    Surgical or Percutaneous Coronary Revascularisation for Heart Failure: An In Silico Model using Routinely Collected Health Data to Emulate a Clinical Trial.
    Eur Heart J. 2022 Nov 9. pii: 6815617. doi: 10.1093.
    >> Share

  138. HEUTS S, Gollmann-Tepekoylu C, Denessen EJS, Olsthoorn JR, et al
    Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications.
    Eur Heart J. 2022 Nov 7. pii: 6807330. doi: 10.1093.
    >> Share

    October 2022
  139. VERGALLO R, Volpe M
    Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR.
    Eur Heart J. 2022 Oct 26. pii: 6774407. doi: 10.1093.
    >> Share

  140. YANG Y, Xie L, Qian H, Cui K, et al
    Minimally invasive videoscope-assisted cardiac surgery for paroxysmal atrial tachycardia originating from right atrial appendage.
    Eur Heart J. 2022 Oct 26. pii: 6774389. doi: 10.1093.
    >> Share

  141. MAN JP, Bouma BJ, Schuuring MJ
    Fusion imaging in preoperative planning of mitral valve surgery to prevent injury of the left circumflex artery.
    Eur Heart J. 2022 Oct 22. pii: 6769829. doi: 10.1093.
    >> Share

  142. ARMILLOTTA M, Foa A, Pizzi C
    Cardiac troponin elevation after coronary artery bypass graft: improving risk stratification.
    Eur Heart J. 2022 Oct 20. pii: 6763997. doi: 10.1093.
    >> Share

  143. VERGALLO R, Liuzzo G
    The REVIVED-BCIS2 trial: percutaneous coronary intervention vs. optimal medical therapy for stable patients with severe ischaemic cardiomyopathy.
    Eur Heart J. 2022 Oct 10. pii: 6754626. doi: 10.1093.
    >> Share

    September 2022
  144. ARMSTRONG PW, Bates ER, Gaudino M
    Left main coronary disease: evolving management concepts.
    Eur Heart J. 2022 Sep 29. pii: 6731216. doi: 10.1093.
    >> Share

  145. TEN BERG J, Rocca B, Angiolillo DJ, Hayashida K, et al
    The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties.
    Eur Heart J. 2022 Sep 21. pii: 6708420. doi: 10.1093.
    >> Share


  146. Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Sep 15. pii: 6701590. doi: 10.1093.
    >> Share

  147. VERGALLO R, Patrono C
    Antiplatelet therapy to prevent graft failure after coronary artery bypass graft: aspirin monotherapy for most, DAPT for selected few.
    Eur Heart J. 2022 Sep 14. pii: 6697011. doi: 10.1093.
    >> Share

  148. HAN Y
    Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement.
    Eur Heart J. 2022 Sep 14. pii: 6697004. doi: 10.1093.
    >> Share

  149. KO KY, Hong GR, Lee SH
    Novel technique of sutureless pulmonic valve replacement for quadricuspid pulmonic valve with huge pulmonary artery aneurysm.
    Eur Heart J. 2022;43:3183.
    >> Share

    August 2022
  150. HALVORSEN S, Mehilli J, Cassese S, Hall TS, et al
    2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.
    Eur Heart J. 2022 Aug 26. pii: 6675076. doi: 10.1093.
    >> Share

  151. ZHANG X, Wang H, Guo Y, Peng Y, et al
    Aortic root 'sink down' caused mitral stenosis after aortic valve replacement: a rare presentation of Bechet's disease.
    Eur Heart J. 2022 Aug 18. pii: 6670978. doi: 10.1093.
    >> Share

  152. DE CATERINA R, Agewall S, Andreotti F, Angiolillo DJ, et al
    Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Aug 4. pii: 6655770. doi: 10.1093.
    >> Share

  153. CREA F
    Challenges in the management of aortic stenosis, multiple valve disease, culture-negative endocarditis, and cardiac surgery during pregnancy.
    Eur Heart J. 2022;43:2715-2719.
    >> Share

  154. KONG WKF, Salsano A, Giacobbe DR, Popescu BA, et al
    Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry.
    Eur Heart J. 2022;43:2770-2780.
    >> Share

  155. HAHN RT, Pibarot P, Otto CM
    Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease.
    Eur Heart J. 2022;43:2767-2769.
    >> Share

  156. ANDREOTTI F, Massetti M, Ten Berg J
    Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS.
    Eur Heart J. 2022;43:2798-2800.
    >> Share

  157. ZHAO ZG, Chen F, Wei X, Feng Y, et al
    Transcatheter mitral valve implantation in severely calcified rheumatic mitral stenosis without annular calcification.
    Eur Heart J. 2022 Aug 1. pii: 6652910. doi: 10.1093.
    >> Share

    July 2022
  158. ORTEGA-PAZ L, Angiolillo DJ
    Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention.
    Eur Heart J. 2022 Jul 21. pii: 6647789. doi: 10.1093.
    >> Share

  159. CREA F
    The challenge of risk stratification in aortic aneurysms, congenital heart disease, and coronary bypass surgery.
    Eur Heart J. 2022;43:2343-2346.
    >> Share

  160. GAUDINO M, Farkouh ME, Stone GW
    Left main revascularization: an evidence-based reconciliation.
    Eur Heart J. 2022;43:2421-2424.
    >> Share

  161. RYCHIK J
    You can only change what you measure: an argument for more detailed characterization in the Fontan circulation.
    Eur Heart J. 2022;43:2385-2387.
    >> Share

  162. INAI K, Inuzuka R, Ono H, Nii M, et al
    Predictors of long-term mortality among perioperative survivors of Fontan operation.
    Eur Heart J. 2022;43:2373-2384.
    >> Share

    June 2022
  163. VERGALLO R, Volpe M
    The UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis.
    Eur Heart J. 2022 Jun 25. pii: 6617779. doi: 10.1093.
    >> Share

  164. CREA F
    The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation.
    Eur Heart J. 2022;43:2165-2169.
    >> Share

  165. KHAIRY P, Silka MJ, Moore JP, DiNardo JA, et al
    Sudden cardiac death in congenital heart disease.
    Eur Heart J. 2022;43:2103-2115.
    >> Share

  166. HAN Y
    Current clinical data and experience of TAVR in China.
    Eur Heart J. 2022;43:2087-2088.
    >> Share

  167. BRAUNWALD E
    Cardiac xenotransplantation: a new path for the treatment of advanced heart failure?
    Eur Heart J. 2022 Jun 4. pii: 6601572. doi: 10.1093.
    >> Share

  168. BELLUSCHI I, Buzzatti N, Denti P, Maisano F, et al
    Transcatheter lithotripsy to facilitate post-dilatation of underexpanded aortic transcatheter heart valve.
    Eur Heart J. 2022;43:2081.
    >> Share

    May 2022
  169. GANESANANTHAN S, Rajkumar CA, Foley M, Thompson D, et al
    Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
    Eur Heart J. 2022 May 26. pii: 6593472. doi: 10.1093.
    >> Share

  170. COLLET JP, Van Belle E, Thiele H, Berti S, et al
    Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
    Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
    >> Share

  171. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    >> Share

  172. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
    Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
    Eur Heart J. 2022;43:1884.
    >> Share

  173. GALIUTO L, Massetti M
    To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
    Eur Heart J. 2022;43:1792-1793.
    >> Share

  174. VAN STEENBERGEN GJ, Tsang QHY, van der Heijden OWH, Vart P, et al
    Timing of cardiac surgery during pregnancy: a patient-level meta-analysis.
    Eur Heart J. 2022 May 13. pii: 6585605. doi: 10.1093.
    >> Share

  175. BEDEIR K, Robichaux RP, Gleason TG
    Surgical whole valve embolization 15 years after implantation.
    Eur Heart J. 2022;43:1685.
    >> Share

  176. JANG SJ, Chen YH, Shen TC
    Pitfalls in recapture or repositioning of Evolut system using cusp overlap technique.
    Eur Heart J. 2022;43:1684.
    >> Share

    April 2022
  177. WINDECKER S, Okuno T, Unbehaun A, Mack M, et al
    Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?
    Eur Heart J. 2022 Apr 25. pii: 6572863. doi: 10.1093.
    >> Share

  178. DAYAN V, Gomes WJ
    The new ESC/EACTS recommendations for transcatheter aortic valve implantation go too far.
    Eur Heart J. 2022 Apr 25. pii: 6572861. doi: 10.1093.
    >> Share

  179. THIELE H, Collet JP, Leon M, Mehran R, et al
    The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
    Eur Heart J. 2022 Apr 25. pii: 6572862. doi: 10.1093.
    >> Share

  180. CRESPO-LEIRO MG, Costanzo MR, Gustafsson F, Khush KK, et al
    Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies.
    Eur Heart J. 2022 Apr 20. pii: 6571226. doi: 10.1093.
    >> Share

  181. CALCAGNO S, Di Pietro R, Biondi-Zoccai G, Versaci F, et al
    Cerebral protection device out of transcatheter heart procedures: a bridge to surgery.
    Eur Heart J. 2022;43:1598.
    >> Share

  182. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
    Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
    Eur Heart J. 2022;43:1599.
    >> Share


  183. Corrigendum to: P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
    Eur Heart J. 2022 Apr 8. pii: 6565204. doi: 10.1093.
    >> Share

  184. BATRA G, Aktaa S, Wallentin L, Maggioni AP, et al
    Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
    Eur Heart J. 2022 Apr 5. pii: 6563567. doi: 10.1093.
    >> Share

    March 2022
  185. CREA F
    Percutaneous coronary intervention vs. coronary artery bypass graft: the saga continues.
    Eur Heart J. 2022;43:1273-1276.
    >> Share

  186. HAN Y, Li Y
    Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?
    Eur Heart J. 2022 Mar 17. pii: 6549760. doi: 10.1093.
    >> Share

  187. THYGESEN K, Jaffe AS
    Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting.
    Eur Heart J. 2022 Mar 17. pii: 6549761. doi: 10.1093.
    >> Share

  188. TURGEON RD, Koshman SL, Dong Y, Graham MM, et al
    P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
    Eur Heart J. 2022 Mar 17. pii: 6549798. doi: 10.1093.
    >> Share

    February 2022
  189. LIUZZO G, Volpe M
    Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate.
    Eur Heart J. 2022 Feb 21. pii: 6533241. doi: 10.1093.
    >> Share

  190. RUDOLPH V
    Heart and kidney: towards an integrated approach to secondary mitral regurgitation.
    Eur Heart J. 2022 Feb 18. pii: 6530471. doi: 10.1093.
    >> Share

  191. GIANNITSIS E, Frey N
    Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best.
    Eur Heart J. 2022 Feb 17. pii: 6530230. doi: 10.1093.
    >> Share

  192. OMRAN H, Deutsch MA, Groezinger E, Zittermann A, et al
    High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making.
    Eur Heart J. 2022 Feb 15. pii: 6528587. doi: 10.1093.
    >> Share

  193. SCHMIADY MO, Carrel T, Sigler M, Eildermann K, et al
    Transcatheter mitral valve in ring implantation: a word of caution based on histopathological workup.
    Eur Heart J. 2022 Feb 15. pii: 6528555. doi: 10.1093.
    >> Share

  194. COLOMBO A, Maisano F
    A new tool for the forgotten valve: a score to predict the risk of surgery.
    Eur Heart J. 2022;43:663-665.
    >> Share

  195. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
    Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
    Eur Heart J. 2022;43:666-679.
    >> Share

  196. POLZL L, Thielmann M, Cymorek S, Nagele F, et al
    Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.
    Eur Heart J. 2022 Feb 9. pii: 6525341. doi: 10.1093.
    >> Share

  197. IUNG B, Urena M
    New insights into transcatheter edge-to-edge repair: filling a gap for undertreatment of primary mitral regurgitation in the elderly?
    Eur Heart J. 2022;0.
    >> Share

  198. DE CATERINA R, Liga R, Boden WE
    Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence.
    Eur Heart J. 2022;43:387-390.
    >> Share

  199. FENG D, Zhang C, Wang J, Lin B, et al
    Simultaneous transcatheter aortic mitral and tricuspid valve-in-valve implantation.
    Eur Heart J. 2022;43:433.
    >> Share

  200. BEOHAR N, Ailawadi G, Kotinkaduwa LN, Redfors B, et al
    Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial.
    Eur Heart J. 2022 Feb 3. pii: 6521532. doi: 10.1093.
    >> Share

    January 2022
  201. DREGOESC MI, Istrate M, Sandu I, Iancu AC, et al
    Massive biventricular thrombosis after transfemoral transcatheter aortic valve implantation.
    Eur Heart J. 2022 Jan 28. pii: 6516865. doi: 10.1093.
    >> Share

  202. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
    Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
    Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
    >> Share

  203. RYAN M, Morgan H, Chiribiri A, Nagel E, et al
    Myocardial viability testing: all STICHed up, or about to be REVIVED?
    Eur Heart J. 2022;43:118-126.
    >> Share

    December 2021
  204. BENEDETTO U, Dimagli A, Kaura A, Sinha S, et al
    Determinants of outcomes following surgery for type A acute aortic dissection: the UK National Adult Cardiac Surgical Audit.
    Eur Heart J. 2021;43:44-52.
    >> Share

  205. WANG R, Serruys PW, Gao C, Hara H, et al
    Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
    Eur Heart J. 2021;43:56-67.
    >> Share

  206. BODEN WE, De Caterina R, Taggart DP
    Is there equivalence between PCI and CABG surgery in long-term survival of patients with diabetes? Importance of interpretation biases and biological plausibility.
    Eur Heart J. 2021;43:68-70.
    >> Share

  207. BULLUCK H, Thygesen K, Hausenloy DJ
    Prognostically relevant cardiac troponin elevations with percutaneous coronary interventions.
    Eur Heart J. 2021 Dec 21. pii: 6471438. doi: 10.1093.
    >> Share

  208. ALFONSO F, Rivero F, Segovia-Cubero J
    Early diagnosis of cardiac allograft vasculopathy: biopsy, liquid biopsy, non-invasive imaging, coronary imaging, or coronary physiology?
    Eur Heart J. 2021;42:4930-4933.
    >> Share

  209. CREA F
    Percutaneous coronary interventions: more complex than fixing stenoses.
    Eur Heart J. 2021;42:4607-4611.
    >> Share

  210. NAVARESE EP, Andreotti F
    Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes.
    Eur Heart J. 2021;42:4699-4700.
    >> Share

  211. ABELLAS-SEQUEIROS M, Pardo Sanz A, Sanchez-Recalde A, Sanmartin-Fernandez M, et al
    Traumatic coronary artery dissection with total occlusion of left descending coronary artery: to stent or not to stent.
    Eur Heart J. 2021;42:4701.
    >> Share

  212. BROWN DL, Boden WE
    Impact of revascularisation on outcomes in chronic coronary syndromes: a new meta-analysis with the same old biases?
    Eur Heart J. 2021;42:4652-4655.
    >> Share

  213. ERLINGE D, Gotberg M
    We need intracoronary physiology guidance before percutaneous coronary intervention, but do we need it post-stenting?
    Eur Heart J. 2021;42:4669-4670.
    >> Share

    November 2021
  214. BAUMGARTNER H
    Aortic stenosis management in 2021: better teaming up than fighting between specialties.
    Eur Heart J. 2021 Nov 28. pii: 6445126. doi: 10.1093.
    >> Share

  215. NGUYEN V, Willner N, Eltchaninoff H, Burwash IG, et al
    Trends in aortic valve replacement for aortic stenosis: a French nationwide study.
    Eur Heart J. 2021 Nov 25. pii: 6439994. doi: 10.1093.
    >> Share

  216. EGGERS KM, James SK, Lindahl B
    Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
    Eur Heart J. 2021 Nov 24. pii: 6438090. doi: 10.1093.
    >> Share

  217. CHIKWE J, Alfieri OR
    The optimal strategy for multivessel coronary revascularization.
    Eur Heart J. 2021 Nov 11. pii: 6425621. doi: 10.1093.
    >> Share

  218. MICHOWITZ Y, Kronborg MB, Glikson M, Nielsen JC, et al
    The '10 commandments' for the 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy.
    Eur Heart J. 2021;42:4295.
    >> Share

  219. PASQUALIN G, Sturla F, D'Aiello AF, Chessa M, et al
    Mixed reality navigation of a systemic venous baffle obstruction: unravelling the percutaneous approach in atrial switch operation.
    Eur Heart J. 2021;42:4284.
    >> Share

    October 2021
  220. AHN JM, Zimmermann FM, Arora S, Solberg OG, et al
    Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.
    Eur Heart J. 2021 Oct 19. pii: 6401958. doi: 10.1093.
    >> Share

  221. ESCANED J, Cao D, Baber U, Nicolas J, et al
    Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
    Eur Heart J. 2021 Oct 18. pii: 6400337. doi: 10.1093.
    >> Share

  222. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
    Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
    Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
    >> Share

    September 2021
  223. DREYFUS J, Audureau E, Bohbot Y, Coisne A, et al
    TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.
    Eur Heart J. 2021 Sep 29. pii: 6377884. doi: 10.1093.
    >> Share

  224. VAHANIAN A, Praz F, Milojevic M, Beyersdorf F, et al
    The "ten commandments" for the 2021 ESC/EACTS Guidelines on valvular heart disease.
    Eur Heart J. 2021 Sep 16. pii: 6371303. doi: 10.1093.
    >> Share

  225. MANCINI D, Gibson GT, Rangasamy S
    Improving survival after heart transplantation despite increasing complexity.
    Eur Heart J. 2021 Sep 3. pii: 6363624. doi: 10.1093.
    >> Share

  226. MESSIKA-ZEITOUN D, Hibbert B, Chan V
    'Primary' percutaneous mitral valve repair in patients with acute myocardial infarction: is it ready for primetime?
    Eur Heart J. 2021 Sep 2. pii: 6362540. doi: 10.1093.
    >> Share

    August 2021
  227. HABERMAN D, Estevez-Loureiro R, Benito-Gonzalez T, Denti P, et al
    Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction.
    Eur Heart J. 2021 Aug 31. pii: 6360026. doi: 10.1093.
    >> Share

  228. VAHANIAN A, Beyersdorf F, Praz F, Milojevic M, et al
    2021 ESC/EACTS Guidelines for the management of valvular heart disease.
    Eur Heart J. 2021 Aug 28. pii: 6358470. doi: 10.1093.
    >> Share

  229. KLOECKNER M, Guihaire J, Hascoet S
    Congestive pulmonary oedema during venoarterial extracorporeal membrane oxygenation support: a plea for balloon atrial septostomy.
    Eur Heart J. 2021;42:3103-3104.
    >> Share

  230. LAURI FM, Fernandez-Golfin C, Zamorano JL, Sanchez-Recalde A, et al
    Coronary compression caused by extrinsic adventitial damage: case of an early complication of trans-catheter tricuspid annuloplasty with cardioband device.
    Eur Heart J. 2021 Aug 18. pii: 6354189. doi: 10.1093.
    >> Share

  231. TEN BERG J
    Antithrombotic therapy in patients undergoing trans catheter aortic valve implantation.
    Eur Heart J. 2021 Aug 9. pii: 6346754. doi: 10.1093.
    >> Share

  232. DANGAS G, Nicolas J, Mehran R
    Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data.
    Eur Heart J. 2021 Aug 9. pii: 6346755. doi: 10.1093.
    >> Share

  233. ZHU Y, Lingala B, Baiocchi M, Toro Arana V, et al
    The Stanford experience of heart transplantation over five decades.
    Eur Heart J. 2021 Aug 1. pii: 6333296. doi: 10.1093.
    >> Share

    September 2020
  234. DELGADO V, Ajmone Marsan N, Bax JJ
    The difficult decision of when and in whom to perform isolated tricuspid valve surgery.
    Eur Heart J. 2020 Sep 27. pii: 5912178. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016